Kenichi Umehara
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 27
- Drug-Induced Hepatotoxicity and Protection 3
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 28
- HER2/EGFR in Cancer Research 3
-
- Pharmacological Effects and Toxicity Studies 8
- Pharmaceutical studies and practices 3
-
- Computational Drug Discovery Methods 8
-
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Gian CamenischHidetaka KamimuraFelix HuthK. NoguchiTakeshi IwatsuboTakashi UsuiNeil ParrottHandan He
- Journals
- Pharmaceutical Research (1 paper)Clinical Pharmacology & Therapeutics (9 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- SwitzerlandUnited StatesJapan
In The Last Decade
Kenichi Umehara
47 papers receiving 889 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 393
- Oncology 487
- Pediatrics, Perinatology and Child Health 213
- Computational Theory and Mathematics 113
- Genetics 68
Countries citing papers authored by Kenichi Umehara
This map shows the geographic impact of Kenichi Umehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Umehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Umehara more than expected).
Fields of papers citing papers by Kenichi Umehara
This network shows the impact of papers produced by Kenichi Umehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Umehara. The network helps show where Kenichi Umehara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenichi Umehara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 9 | |
| 9 | 2020 | 28 | |
| 10 | 2020 | 4 | |
| 11 | 2019 | 8 | |
| 12 | 2019 | 29 | |
| 13 | 2016 | 16 | |
| 14 | 2016 | 13 | |
| 15 | 2011 | 52 | |
| 16 | 2009 | 4 | |
| 17 | 2008 | 0 | |
| 18 | 2008 | 8 | |
| 19 | 2008 | 32 | |
| 20 | 2007 | 34 |
About Kenichi Umehara
Kenichi Umehara is a scholar working on Pharmacology, Oncology and Biochemistry, having authored 52 papers that have together received 908 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (28 papers), Pharmacogenetics and Drug Metabolism (27 papers), Computational Drug Discovery Methods (8 papers), Pharmacological Effects and Toxicity Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers), HER2/EGFR in Cancer Research (3 papers), Pharmaceutical studies and practices (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Pharmacology (393 citations), Oncology (487 citations) and Pediatrics, Perinatology and Child Health (213 citations). Kenichi Umehara has collaborated with scholars based in Switzerland, United States and Japan. Frequent co-authors include Gian Camenisch, Hidetaka Kamimura, Felix Huth, K. Noguchi, Takeshi Iwatsubo, Takashi Usui, Neil Parrott, Handan He, Stephen Fowler and Hilmar Schiller. Their work appears in journals such as Pharmaceutical Research, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.